middle.news
ImpediMed Doubles US Sales, Unlocks $5M Growth Capital Tranche
9:55am on Wednesday 16th of July, 2025 AEST
•
Healthcare
Read Story
ImpediMed Doubles US Sales, Unlocks $5M Growth Capital Tranche
9:55am on Wednesday 16th of July, 2025 AEST
Key Points
US unit sales doubled to 44 in Q4 FY25
Record quarterly total contract value of A$6.3 million
Secured additional US$5 million tranche from SWK Funding LLC
Key 9-unit contract with Legacy Health for lymphoedema prevention
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Impedimed (ASX:IPD)
OPEN ARTICLE